Malignant Tumors Misdiagnosed as Liver Hemangiomas

dc.contributor.authorYıldırım, Murat Baki
dc.contributor.authorŞahiner, İbrahim Tayfun
dc.contributor.authorPoyanlı, Arzu
dc.contributor.authorAcunaş, Bülent
dc.contributor.authorGüllüoğlu, Mine
dc.contributor.authorİbiş, Cem
dc.contributor.authorÖzden, Ilgın
dc.date.accessioned2021-11-01T15:05:38Z
dc.date.available2021-11-01T15:05:38Z
dc.date.issued2021
dc.departmentHitit Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü
dc.description.abstractBackground and Aim: To derive lessons from the data of patients who were followed for various periods with the misdiagnosis of liver hemangioma and eventually found to have a malignancy. Material and Methods: The records of 23 patients treated between 2003 and 2018 were analyzed retrospectively. Results: Twelve patients were men and 11 were women; median (range) age was 55 (35-80). The principal diagnostic modality for the initial diagnosis was ultrasonography (n:8), magnetic resonance imaging (MRI) (n:13), and computed tomography (CT) (n:2). At our institution, MRI was performed in 16 patients; the diagnosis was made with the available MRI and CT studies in five and two patients, respectively. In other words, the ultrasonography interpretations were not confirmed on MRI; in others, the MRI or CT examinations were of low quality or they had not been interpreted properly. Fifteen patients underwent surgery; the other patients received chemotherapy (n:6) or chemoembolization (n:2). The misdiagnosis caused a median (range) 10 (0-96) months delay in treatment. The final diagnoses were hepatocellular carcinoma in 12 patients, cholangiocarcinoma in four patients, metastatic mesenchymal tumor, metastasis of colon cancer, metastatic neuroendocrine carcinoma, sarcomatoid hepatocellular carcinoma, angiosarcoma, thoracic wall tumor, and metastatic tumor of unknown primary in one patient each. Conclusions: High-quality MRI with proper interpretation and judicious follow up are vital for the accurate differential diagnosis of liver lesions.
dc.identifier.citationYıldırım, M. B., Şahiner, İ. T., Poyanlı, A., Acunaş, B., Güllüo?lu, M., İbiş, C., ... & Özden, İ. (2021). Malignant Tumors Misdiagnosed as Liver Hemangiomas. Frontiers in surgery, 8.
dc.identifier.doi10.3389/fsurg.2021.715429
dc.identifier.issn2296-875X
dc.identifier.pmid34458317
dc.identifier.scopus2-s2.0-85113459926
dc.identifier.scopusqualityQ2
dc.identifier.urihttps://doi.org/10.3389/fsurg.2021.715429
dc.identifier.urihttps://hdl.handle.net/11491/7354
dc.identifier.volume8en_US
dc.identifier.wosWOS:000687883400001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorYıldırım, Murat Baki
dc.institutionauthorŞahiner, İbrahim Tayfun
dc.language.isoen
dc.publisherFrontiers Media Sa
dc.relation.ispartofFrontiers In Surgery
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectHemangiomaen_US
dc.subjectAtypical hemangiomaen_US
dc.subjectMisdiagnosisen_US
dc.subjectLiver malignancyen_US
dc.subjectMalign massen_US
dc.titleMalignant Tumors Misdiagnosed as Liver Hemangiomas
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
murat-baki-yildirim2021.pdf
Boyut:
146.52 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text